bay1101042
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 15, 2017 (NCT03235076)
Timeline
Indications
Mechanism of action
NPR1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04820621 | Phase 1 | Apr 7, 2021 | Bayer |
| NCT04722991 | Phase 2 | Mar 17, 2021 | Bayer |
| NCT03252002 | Phase 1 | Aug 16, 2017 | Bayer |
| NCT03235076 | Phase 1 | Aug 15, 2017 | Bayer |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bayer | For profit | 4 | 4 | 2 | 2017 |
1 organizations
Page 1 / 1